07:33 AM EDT, 05/05/2025 (MT Newswires) -- Twist Bioscience ( TWST ) reported a fiscal Q2 net loss Monday of $0.66 per diluted share, narrowing from $0.79 a year earlier.

Analysts polled by FactSet expected a $0.58 loss.

Revenue for the quarter ended March 31 was $92.8 million, compared with $75.3 million a year earlier.

Analysts polled by FactSet expected $92 million.

The company said it expects fiscal Q3 revenue of $94 million to $97 million. Analysts polled by FactSet expect $95.5 million.

For fiscal 2025, Twist Bioscience ( TWST ) reiterated its revenue outlook of $372 million to $379 million. Analysts polled by FactSet expect $375.8 million.